In vivo study of inhibitory impact of herbal medicine on prostate cancer tumor: An endemic specie of Lamiaceae family
In vivo study of inhibitory impact of herbal medicine on prostate cancer tumor: An endemic specie of Lamiaceae family
Shaghayegh Zabihollahi1 Mohsen Taghavijeloudar2
1) MSc. Department of Biology, University of Mazandaran, Babolsar, Iran.
2) PhD. Department of Civil and Environmental Engineering, Seoul National University, Seoul, Korea. Email:
IOI Code
:
AZEK-AADHGZ
Publication :
4th International Conference on New Research & Achievements in Science, Engineering & Technologies(setbconf.com)
Abstract :
The use of herbal medicine for cancer treatment has gained considerable attention due to its minimal side effects compared to conventional therapies such as chemotherapy. Among various cancers, prostate cancer (PC) is one of the leading causes of cancer-related mortality in men. In this study, Teucrium hyrcanicum, an endemic plant in Iran and neighboring countries belonging to the Lamiaceae family, was investigated for the first time as a potential herbal treatment for prostate cancer (PC-3) tumors at the in vivo level. Traditionally used in herbal medicine, T. hyrcanicum is rich in bioactive compounds such as flavonoids and phenolic acids. Previous studies have demonstrated its antioxidant, antimicrobial, and potential anticancer properties, primarily at the in vitro level. The current in vivo findings indicate that T. hyrcanicum significantly reduces tumor volume and weight. According to the xenograft mouse model results, treatment with T. hyrcanicum leaf extract at its IC50 concentration reduced prostate tumor volume from 2750 mm³ to 510 mm³ and tumor weight from 1.16 g to 0.22 g over 30 days. These results suggest that T. hyrcanicum holds promising potential as a natural anticancer agent for prostate cancer treatment.
Keywords : alternative cancer treatment teucrium hyrcanicum prostate cancer in vivo study